Meet the Post Testing Consultant Genetic Specialist Team
These genetic specialists are not contracted to BRCATESTUK and provide you with independent support
Dr Alexandra J Murray
Consultant Clinical Geneticist
Cancer Genetics Lead Clinician for the All Wales Medical Genetics ServiceRead moreX
Dr Alexandra J Murray - Consultant Clinical Geneticist
Dr Murray is the Cancer Genetics Lead Clinician for the All Wales Medical Genetics Service, based at the University Hospital of Wales in Cardiff and Singleton Hospital in Swansea.
A member of our post-test counselling team, she is a member of the Wales Cancer Network and is leading the Welsh cancer genetics mainstreaming programme.
She has a particular interest in familial breast and ovarian cancer and is the local principal investigator for several UK-wide breast cancer research studies including the Breast and Ovarian Cancer Susceptibility Study and the Epidemiological Study of Familial Breast Cancer.
Dr Murray has been involved in numerous local research and service evaluation projects and has used the outcomes of these to improve the cancer genetics patient experience. She is also a member of the Target Ovarian Cancer Clinical Advisory Panel.
Dr Gabriella Pichert
Consultant in Cancer Genetics
Dr Pichert has specialised in medical oncology, but since 1999 her focus has been on cancer geneticsRead moreX
Dr Gabriella Pichert - Consultant in Cancer Genetics
Dr Pichert has specialised in medical oncology, but since 1999 her focus has been on cancer genetics, where she has acquired broad knowledge in risk assessment, genetic counselling and management of individuals and families with an inherited predisposition to cancer.
With a background in oncology, Dr Pichert worked as a Consultant in Cancer Genetics in the Department of Clinical Genetics at Guy’s and St Thomas NHS Foundation Trust from 2004 to 2010 and was Joint Lead for Cancer Genetic Services from 2008-2010. During that time Dr Pichert developed a multidisciplinary clinic for the management of carriers with mutations in the BRCA1 and BRCA2 genes and established a multidisciplinary clinic for families with an inherited predisposition to skin cancers.
A member of our post-test counselling team, she is one of the few Cancer Geneticists in private practice in London. Dr Pichert has established a clinic at London Bridge Hospital and can receive referrals from oncologists, GP’s, gastroenterologists, kidney specialists, dermatologists, breast specialists, gynaecologists, urologists and colorectal surgeons.
She provides cancer risk assessment, genetic counselling and advice on the management of individuals and families with an inherited predisposition to cancer, such as women with a personal and/or family history of breast cancer.
Professor Gareth Evans
Consultant in Medical Genetics and Cancer Epidemiology
Consultant at the Central Manchester Hospitals NHS Foundation Trust and The Christie NHS Foundation TrustRead moreX
Professor Gareth Evans - Consultant in Medical Genetics and Cancer Epidemiology
A Consultant at the Central Manchester Hospitals NHS Foundation Trust and The Christie NHS Foundation Trust, Professor Evans has established a national and international reputation in clinical and research aspects of cancer genetics, particularly in neurofibromatosis and breast cancer.
He has published 660 peer reviewed research publications, 247 as first or senior author. He has also published over 100 reviews and chapters and has had a book published by Oxford University Press on familial cancer. He has an ISI web of knowledge H-index of 90 and google scholar of 123 having only published his first article in 1990.
In the last seven years he has raised over £45 million in grants for multicentre and local studies – approximately £38 million in Manchester.
He is Chief Investigator on two NIHR program grants (2009-2014-£1.59 million) (2017-2020-£1million) on breast cancer risk prediction and also has an NIHR RfPB grant as CI (2011). He also led the successful bid for a Nationally funded NF2 service (£7.5 million pa) that started in 2010 and is involved in the national complex NF1 service.
In addition, he is overall cancer lead (three themes) and Cancer Prevention Early detection theme lead on the successful all Manchester NIHR Biomedical research centre bid (2017-2022-£28.5million).
Professor Evans is also lead clinician on the NICE familial breast cancer guideline group and is a trustee of BCN and the Neuro Foundation.